Verona Pharma (VRNA) News Today

$14.85
+0.10 (+0.68%)
(As of 05/10/2024 ET)
SourceHeadline
finance.yahoo.com logoVerona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
finance.yahoo.com - May 10 at 5:45 PM
finance.yahoo.com logoVerona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
finance.yahoo.com - May 10 at 12:45 PM
finanznachrichten.de logoVerona Pharma plc: Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
finanznachrichten.de - May 9 at 8:33 AM
finance.yahoo.com logoVerona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
finance.yahoo.com - May 9 at 8:33 AM
globenewswire.com logoVerona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
globenewswire.com - May 9 at 7:15 AM
globenewswire.com logoVerona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
globenewswire.com - May 9 at 7:00 AM
MarketBeat logoVerona Pharma (NASDAQ:VRNA) Shares Down 4.3% Following Insider Selling
americanbankingnews.com - May 7 at 1:34 AM
marketbeat.com logoVerona Pharma (NASDAQ:VRNA) Shares Down 4.3% on Insider Selling
marketbeat.com - May 6 at 2:03 PM
insidertrades.com logoKathleen A. Rickard Sells 36,248 Shares of Verona Pharma plc (NASDAQ:VRNA) Stock
insidertrades.com - May 5 at 6:04 AM
marketbeat.com logoVerona Pharma plc (NASDAQ:VRNA) Insider Kathleen A. Rickard Sells 36,248 Shares
marketbeat.com - May 3 at 10:24 PM
MarketBeat logoVerona Pharma (VRNA) Set to Announce Quarterly Earnings on Thursday
americanbankingnews.com - May 2 at 3:34 AM
globenewswire.com logoVerona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
globenewswire.com - May 2 at 2:00 AM
marketbeat.com logoVerona Pharma plc (NASDAQ:VRNA) is Vivo Capital LLC's 6th Largest Position
marketbeat.com - April 27 at 9:40 PM
marketbeat.com logoJennison Associates LLC Acquires 142,819 Shares of Verona Pharma plc (NASDAQ:VRNA)
marketbeat.com - April 25 at 7:26 AM
investing.com logoVerona Pharma shares target raised on COPD launch outlook
investing.com - April 25 at 3:40 AM
globenewswire.com logoVerona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update
globenewswire.com - April 25 at 2:00 AM
marketbeat.com logoVerona Pharma (NASDAQ:VRNA) Stock Price Up 3.7% on Analyst Upgrade
marketbeat.com - April 16 at 10:36 AM
marketbeat.com logoVerona Pharma (NASDAQ:VRNA) PT Raised to $36.00 at Piper Sandler
marketbeat.com - April 16 at 8:33 AM
marketbeat.com logoVerona Pharma (NASDAQ:VRNA) Shares Up 4.9%
marketbeat.com - April 4 at 3:08 PM
marketbeat.com logoAmerican Century Companies Inc. Purchases Shares of 280,126 Verona Pharma plc (NASDAQ:VRNA)
marketbeat.com - March 28 at 4:07 AM
marketbeat.com logoWellington Management Group LLP Acquires 164,268 Shares of Verona Pharma plc (NASDAQ:VRNA)
marketbeat.com - March 19 at 4:54 AM
finance.yahoo.com logoVRNA Apr 2024 17.500 call
finance.yahoo.com - March 16 at 8:32 AM
finance.yahoo.com logoVRNA Apr 2024 15.000 call
finance.yahoo.com - March 16 at 3:31 AM
marketbeat.com logoVerona Pharma (NASDAQ:VRNA) Trading Down 7.6%
marketbeat.com - March 14 at 12:47 PM
marketbeat.com logoAdage Capital Partners GP L.L.C. Buys 208,100 Shares of Verona Pharma plc (NASDAQ:VRNA)
marketbeat.com - March 10 at 6:37 AM
marketbeat.com logoResearch Analysts Set Expectations for Verona Pharma plc's Q3 2024 Earnings (NASDAQ:VRNA)
marketbeat.com - March 7 at 7:22 AM
marketbeat.com logoVerona Pharma plc (NASDAQ:VRNA) Forecasted to Post Q4 2025 Earnings of ($0.01) Per Share
marketbeat.com - March 6 at 8:32 AM
marketbeat.com logoVerona Pharma (NASDAQ:VRNA) Stock Rating Reaffirmed by HC Wainwright
marketbeat.com - March 4 at 8:25 AM
globenewswire.com logoAndrew Fisher Joins Verona Pharma as General Counsel
globenewswire.com - March 4 at 2:00 AM
markets.businessinsider.com logoBuy Rating Affirmed: Verona Pharma’s Promising Future with Ensifentrine and Expanding R&D Pipeline
markets.businessinsider.com - March 1 at 1:10 PM
finance.yahoo.com logoVerona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 1 at 1:10 PM
marketbeat.com logoVerona Pharma (NASDAQ:VRNA) Rating Reiterated by Wedbush
marketbeat.com - March 1 at 9:16 AM
fool.com logo3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
fool.com - March 1 at 8:45 AM
seekingalpha.com logoVerona Pharma plc 2023 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 29 at 11:18 AM
finanznachrichten.de logoVerona Pharma plc: Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - February 29 at 10:48 AM
finance.yahoo.com logoVerona Pharma PLC Reports Fourth Quarter and Full Year 2023 Financial Results
finance.yahoo.com - February 29 at 10:48 AM
globenewswire.com logoVerona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
globenewswire.com - February 29 at 2:00 AM
markets.businessinsider.com logoVerona Pharma earnings preview: what to expect
markets.businessinsider.com - February 28 at 1:35 PM
marketbeat.com logoAvidity Partners Management LP Sells 124,200 Shares of Verona Pharma plc (NASDAQ:VRNA)
marketbeat.com - February 27 at 4:26 PM
finance.yahoo.com logoWhen Will Verona Pharma plc (NASDAQ:VRNA) Turn A Profit?
finance.yahoo.com - February 25 at 12:52 PM
wsj.com logoVerona Pharma PLC ADR
wsj.com - February 25 at 7:52 AM
marketbeat.com logoFederated Hermes Inc. Has $40.65 Million Stock Position in Verona Pharma plc (NASDAQ:VRNA)
marketbeat.com - February 23 at 8:38 AM
finance.yahoo.com logoVRNA Mar 2024 15.000 put
finance.yahoo.com - February 17 at 7:46 PM
finance.yahoo.com logoVRNA Jun 2024 30.000 call
finance.yahoo.com - February 17 at 2:46 PM
seekingalpha.com logoVerona Pharma: A Few Points From The Bull And Bear Case
seekingalpha.com - February 15 at 5:55 PM
finance.yahoo.com logoVerona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
finance.yahoo.com - February 15 at 10:20 AM
globenewswire.com logoVerona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
globenewswire.com - February 15 at 2:00 AM
marketbeat.com logoVerona Pharma (NASDAQ:VRNA) Trading 2% Higher
marketbeat.com - February 13 at 1:32 PM
marketbeat.com logoCampbell & CO Investment Adviser LLC Takes Position in Verona Pharma plc (NASDAQ:VRNA)
marketbeat.com - February 11 at 7:17 AM
marketbeat.com logoVerona Pharma (NASDAQ:VRNA) Trading Down 5.3%
marketbeat.com - February 2 at 1:37 PM
Get Verona Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter.

The Crypto 9-5 Escape Plan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide

VRNA Media Mentions By Week

VRNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VRNA
News Sentiment

0.33

0.52

Average
Medical
News Sentiment

VRNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VRNA Articles
This Week

11

2

VRNA Articles
Average Week

Get Verona Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:VRNA) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners